Dementia – Dispatches from AAIC 2026 Episode 39

This episode explores some of the latest dementia research presented at the Alzheimer’s Association International Conference in London, UK, with guest Dr. Rebecca M. Edelmayer, Vice President of Scientific Engagement at the Alzheimer’s Association and a leader in global dementia research and scientific collaboration.

Alongside co-hosts Jay Ingram and Dr. Allison Sekuler, Dr. Edelmayer discusses emerging findings that could shape the future of dementia prevention, treatment and care. Topics include research from two studies on brain changes observed in former professional soccer players and physician-supervised use of an oil containing active ingredients of cannabis, which may calm agitation in people living with dementia, respectively.

The conversation also examines a study in Latin America showing that lifestyle interventions designed to reduce dementia risk can be successfully adapted across different cultures and communities. Together, these studies offer new insights into early detection, risk reduction and improving quality of life for people affected by dementia.

Tune in at defydementia.org, or wherever you get your podcasts.

The content provided herein is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, treatment or guidance on the use of any product or substance. You should always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. In particular, the cannabis-based treatment discussed in this episode was administered by physicians in a specific formulation and dosage under controlled clinical trial conditions and this content is not intended to encourage or provide guidance on the use of cannabis products. The content shared reflects current understanding at the time of publication.